|
Welcome,
Guest
|
Profile for Chimeric Antigen Receptor-modified T tissue targeting EphA2 for your immunotherapy involving paediatric navicular bone tumours. (wintericicle9)
|
Signature
|
|
Welcome,
Guest
|
|
Signature
|